


AtPoint tx
Biotechnology Research • Washington, District of Columbia, United States • 1-10 Employees
Company overview
| Headquarters | 2001 L St NW, Washington, District of Columbia 20036, US |
| Website | |
| Keywords | Biotechnology, Medical Devices, Regenerative Medicine, Cancer, Stem Cells, Cell Therapy, Translational Medicine, Clinical Care, Cell Engineering |
| Founded | 2022 |
| Employees | 1-10 |
Key Contact at AtPoint tx
Rawan Al-Kharboosh
Chief Executive Officer
About AtPoint tx
Washington DC-based biotech startup dedicated to innovating cell-based technologies for treatments at the point-of-care. We believe in the possibility of patients becoming "self-repairing" by using their OWN stem cells to replenish and restore cells in degenerative diseases that have undergone damage. Cellular therapy is 10-15% of all clinical applications today and only rising with an aging population. Led by a team of scientists, our founders and members have previously succeeded in utilizing iterative iPSC technologies for rapid tissue-specific regeneration, and patient-specific primary cellular applications sanctioned by the FDA for investigational use in phase I clinical trials. Our team is innovating novel devices and applications using AI modeling to leverage personalized stem cell therapies for disease-specific needs. Currently approaching our next round, we are dedicated to enhancing stem cell treatment paradigms by changing the face of stem cell technologies at bed-side.
AtPoint tx revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
AtPoint tx has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
AtPoint tx has never raised funding before.
Frequently asked questions
4.8
40,000 users



